Impact of pathologic tumor response in the treatment of gastric cancer

Affiliations

Comment

Joyce Wong. Transl Gastroenterol Hepatol. 2016.

. 2016 Sep 21:1:71.

doi: 10.21037/tgh.2016.09.04. eCollection 2016.

No abstract available

Conflict of interest statement

The author has no conflicts of interest to declare.

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.
Smyth EC, Fassan M, Cunningham D, Allum WH, Okines AF, Lampis A, Hahne JC, Rugge M, Peckitt C, Nankivell M, Langley R, Ghidini M, Braconi C, Wotherspoon A, Grabsch HI, Valeri N. Smyth EC, et al. J Clin Oncol. 2016 Aug 10;34(23):2721-7. doi: 10.1200/JCO.2015.65.7692. Epub 2016 Jun 13. J Clin Oncol. 2016. PMID: 27298411 Free PMC article. Clinical Trial.

1. Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2016. [Epub ahead of print]. - PMC - PubMed
1. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20. 10.1056/NEJMoa055531 - DOI - PubMed
1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Gastric Cancer. Version 3.2016. Available online: https://www.nccn.org/professionals/physician_gls/pdf/gastric_blocks.pdf - PubMed
1. Smyth EC, Fassan M, Cunningham D, et al. Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. J Clin Oncol 2016;34:2721-7. 10.1200/JCO.2015.65.7692 - DOI - PMC - PubMed
1. Thies S, Langer R. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment. Front Oncol 2013;3:262. 10.3389/fonc.2013.00262 - DOI - PMC - PubMed